HABEKACIN

This brand name is authorized in Japan

Active ingredients

The drug HABEKACIN contains one active pharmaceutical ingredient (API):

1 Arbekacin UNII G7395HZ992 - ARBEKACIN SULFATE
Arbekacin is a semisynthetic aminoglycoside antibiotic with activity against both gram-positive and gram-negative bacteria. It is most commonly used in the treatment of multi-resistant bacterial infections such as methicillin-resistant Staphylococcus aureus (MRSA).

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01GB12	Arbekacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 6119400A1069, 6119400A2073, 6119400A3037, 6119400A4025

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.